These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27928744)

  • 1. On vaccination programs in the EU Member States: the case of the human papilloma virus.
    Lorente R; Antonanzas F
    Eur J Health Econ; 2017 Sep; 18(7):801-803. PubMed ID: 27928744
    [No Abstract]   [Full Text] [Related]  

  • 2. Human papillomavirus vaccination: expected impacts and unresolved issues.
    Dempsey AF; Freed GL
    J Pediatr; 2008 Mar; 152(3):305-9. PubMed ID: 18280831
    [No Abstract]   [Full Text] [Related]  

  • 3. An alert to Latin America: Current human papillomavirus vaccination trends highlight key barriers to successful implementation.
    Nogueira-Rodrigues A; Bukowski A; Paulino E; St Louis J; Barrichello A; Sternberg C; Gifoni MAC; Luciani S; Goss PE
    Cancer; 2017 Jun; 123(12):2193-2199. PubMed ID: 28440878
    [No Abstract]   [Full Text] [Related]  

  • 4. Challenges of implementing human papillomavirus (HPV) vaccination policy.
    Raffle AE
    BMJ; 2007 Aug; 335(7616):375-7. PubMed ID: 17717366
    [No Abstract]   [Full Text] [Related]  

  • 5. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE; Vuocolo S
    Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One in four California adolescent girls have had human papillomavirus vaccination.
    Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
    Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
    [No Abstract]   [Full Text] [Related]  

  • 7. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
    Prescrire Int; 2007 Jun; 16(89):91-4. PubMed ID: 17582921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries. A WHO/ICO HPV Information Centre Report.
    de Sanjosé S; Serrano B; Castellsagué X; Brotons M; Muñoz J; Bruni L; Bosch FX
    Vaccine; 2012 Nov; 30 Suppl 4():D1-83, vi. PubMed ID: 23510764
    [No Abstract]   [Full Text] [Related]  

  • 9. Implementation of an HPV vaccination program in Eldoret, Kenya: results from a qualitative assessment by key stakeholders.
    Vermandere H; Naanyu V; Degomme O; Michielsen K
    BMC Public Health; 2015 Sep; 15():875. PubMed ID: 26358701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus, vaccines and women's health: questions and cautions.
    Lippman A; Melnychuk R; Shimmin C; Boscoe M
    CMAJ; 2007 Aug; 177(5):484-7. PubMed ID: 17671239
    [No Abstract]   [Full Text] [Related]  

  • 11. Herd immunity.
    O'Connor K
    Aust Fam Physician; 2007 Sep; 36(9):677. PubMed ID: 17915372
    [No Abstract]   [Full Text] [Related]  

  • 12. HPV-related cancer prevention through coalition building.
    Lind E; Welch K; Perkins RB
    Hum Vaccin Immunother; 2017 Oct; 13(10):2300-2306. PubMed ID: 28901813
    [No Abstract]   [Full Text] [Related]  

  • 13. Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available?
    Porta M; González B; Márquez S; Artazcoz L
    J Epidemiol Community Health; 2008 Aug; 62(8):667. PubMed ID: 18621949
    [No Abstract]   [Full Text] [Related]  

  • 14. Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination.
    Dillner J; Arbyn M; Dillner L
    Clin Exp Immunol; 2007 May; 148(2):199-207. PubMed ID: 17437418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticipating full benefits from the new papillomavirus vaccines.
    Griffiths PD
    Rev Med Virol; 2007; 17(1):1-3. PubMed ID: 17173349
    [No Abstract]   [Full Text] [Related]  

  • 16. Cervical cancer, human papillomavirus, and vaccination.
    Lowndes CM; Gill ON
    BMJ; 2005 Oct; 331(7522):915-6. PubMed ID: 16239668
    [No Abstract]   [Full Text] [Related]  

  • 17. Playing games with girls' health: why it is too soon to mandate the HPV vaccine for pre-teen girls as a prerequisite to school entry.
    Gendel JE
    Seton Hall Law Rev; 2009; 39(1):265-90. PubMed ID: 19288617
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of the first HPV vaccination campaign in two northern Italian health districts.
    Chadenier GM; Colzani E; Faccini M; Borriello CR; Bonazzi C
    Vaccine; 2011 Jun; 29(26):4405-8. PubMed ID: 21501645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parental perspective on human papillomavirus (HPV) vaccination in Serbia: Knowledge, attitudes and practice.
    Marić G; Birčanin Đ; Kisić V; Dotlić J; Zarić M; Kisić-Tepavčević D; Gazibara T
    Sex Reprod Healthc; 2018 Jun; 16():192-198. PubMed ID: 29804766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two doses and not three for the human papilloma virus vaccine in Chile.
    Bachelet VC
    Medwave; 2016 Jan; 16(1):e6373. PubMed ID: 26938044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.